Genetic and Genomic Insights into the Molecular Basis of Atherosclerosis

Cell Metabolism

Volumn 6, Issue 3, 2007, Pages 164-179

  Chen, Yaoyu ^a   Rollins, Jarod ^a   Paigen, Beverly ^a   Wang, Xiaosong ^b  

^a JACKSON LABORATORY   (United States)

^b NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 [3 (4 BIPHENYLYLMETHYL) 4 HYDROXYCHROMAN 7 YL]CYCLOPENTANECARBOXYLIC ACID; ANGIOPOIETIN; ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; CD134 ANTIGEN; CHOLESTEROL; GUANOSINE TRIPHOSPHATASE; LEUKOTRIENE A4 HYDROLASE; LEUKOTRIENE B4; LEUKOTRIENE RECEPTOR; LIPID; MYOCYTE ENHANCER FACTOR 2; NITRIC OXIDE SYNTHASE INHIBITOR; PROTEASOME; RANTES; TRANSCRIPTION FACTOR GATA 1;

ATHEROSCLEROSIS; BIOINFORMATICS; BIOTECHNOLOGY; CHOLESTEROL DIET; CHROMOSOME 12Q; CHROMOSOME 13Q; CHROMOSOME 14P; CHROMOSOME 1P; CHROMOSOME 5P; CHROMOSOME 6P; CHROMOSOME 8Q; DISEASE MODEL; DRUG TARGETING; ENVIRONMENTAL FACTOR; GENE IDENTIFICATION; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HEART INFARCTION; HEREDITY; HUMAN; INDIVIDUALIZATION; INFLAMMATION; LINKAGE ANALYSIS; LIPID DIET; LIPID METABOLISM; MOLECULAR MECHANICS; NONHUMAN; PATHOGENESIS; PATIENT CARE; PHARMACOGENETICS; PHARMACOGENOMICS; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; REVIEW; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOGENESIS;

ANIMALS; ATHEROSCLEROSIS; CHROMOSOME MAPPING; ENZYME INHIBITORS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE (GENETICS); QUANTITATIVE TRAIT LOCI; RISK FACTORS;

MUS;

EID: 34548223196     PISSN: 15504131     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cmet.2007.07.001     Document Type: Review

References (103)

1. Aiello R.J., Bourassa P.A., Lindsey S., Weng W., Freeman A., and Showell H.J. Leukotriene B4 receptor antagonism reduces monocytic foam cells in mice. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 443-449
2. Altshuler D., and Hirschhorn J.N. MEF2A sequence variants and coronary artery disease: a change of heart?. J. Clin. Invest. 115 (2005) 831-833
3. Arnett D.K., Baird A.E., Barkley R.A., Basson C.T., Boerwinkle E., Ganesh S.K., Herrington D.M., Hong Y., Jaquish C., McDermott D.A., and O'Donnell C.J. Relevance of genetics and genomics for prevention and treatment of cardiovascular disease: a scientific statement from the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation 115 (2007) 2878-2901
4. Bhagavatula M.R., Fan C., Shen G.Q., Cassano J., Plow E.F., Topol E.J., and Wang Q. Transcription factor MEF2A mutations in patients with coronary artery disease. Hum. Mol. Genet. 13 (2004) 3181-3188
5. Broeckel U., Hengstenberg C., Mayer B., Holmer S., Martin L.J., Comuzzie A.G., Blangero J., Nurnberg P., Reis A., Riegger G.A., et al. A comprehensive linkage analysis for myocardial infarction and its related risk factors. Nat. Genet. 30 (2002) 210-214
6. Brousseau M.E. Emerging role of high-density lipoprotein in the prevention of cardiovascular disease. Drug Discov. Today 10 (2005) 1095-1101
7. Burgess J.K., Carlin S., Pack R.A., Arndt G.M., Au W.W., Johnson P.R., Black J.L., and Hunt N.H. Detection and characterization of OX40 ligand expression in human airway smooth muscle cells: a possible role in asthma?. J. Allergy Clin. Immunol. 113 (2004) 683-689
8. Camenisch G., Pisabarro M.T., Sherman D., Kowalski J., Nagel M., Hass P., Xie M.H., Gurney A., Bodary S., Liang X.H., et al. ANGPTL3 stimulates endothelial cell adhesion and migration via integrin alpha vbeta 3 and induces blood vessel formation in vivo. J. Biol. Chem. 277 (2002) 17281-17290
9. Chen A.I., McAdam A.J., Buhlmann J.E., Scott S., Lupher Jr. M.L., Greenfield E.A., Baum P.R., Fanslow W.C., Calderhead D.M., Freeman G.J., and Sharpe A.H. Ox40-ligand has a critical costimulatory role in dendritic cell:T cell interactions. Immunity 11 (1999) 689-698
10. Chiodini B.D., and Lewis C.M. Meta-analysis of 4 coronary heart disease genome-wide linkage studies confirms a susceptibility locus on chromosome 3q. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 1863-1868
11. Cipollone F., Ferri C., Desideri G., Paloscia L., Materazzo G., Mascellanti M., Fazia M., Iezzi A., Cuccurullo C., Pini B., et al. Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty. Circulation 108 (2003) 2776-2782
12. Clarke R., Xu P., Bennett D., Lewington S., Zondervan K., Parish S., Palmer A., Clark S., Cardon L., Peto R., et al. Lymphotoxin-alpha gene and risk of myocardial infarction in 6,928 cases and 2,712 controls in the ISIS case-control study. PLoS Genet. 2 (2006) e107
13. Colinayo V.V., Qiao J.H., Wang X., Krass K.L., Schadt E., Lusis A.J., and Drake T.A. Genetic loci for diet-induced atherosclerosis lesions and plasma lipids in mice. Mamm. Genome 14 (2003) 464-471
14. Connelly J.J., Wang T., Cox J.E., Haynes C., Wang L., Shah S.H., Crosslin D.R., Hale A.B., Nelson S., Crossman D.C., et al. GATA2 is associated with familial early-onset coronary artery disease. PLoS Genet. 2 (2006) e139
15. Dansky H.M., Shu P., Donavan M., Montagno J., Nagle D.L., Smutko J.S., Roy N., Whiteing S., Barrios J., McBride T.J., et al. A phenotype-sensitizing Apoe-deficient genetic background reveals novel atherosclerosis predisposition loci in the mouse. Genetics 160 (2002) 1599-1608
16. de Winther M.P., Kanters E., Kraal G., and Hofker M.H. Nuclear factor kappaB signaling in atherogenesis. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 904-914
17. DiPetrillo K., Wang X., Stylianou I.M., and Paigen B. Bioinformatics toolbox for narrowing rodent quantitative trait loci. Trends Genet. 21 (2005) 683-692
18. Dwyer J.H., Allayee H., Dwyer K.M., Fan J., Wu H., Mar R., Lusis A.J., and Mehrabian M. Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. N. Engl. J. Med. 350 (2004) 29-37
19. Farrall M., Green F.R., Peden J.F., Olsson P.G., Clarke R., Hellenius M.L., Rust S., Lagercrantz J., Franzosi M.G., Schulte H., et al. Genome-wide mapping of susceptibility to coronary artery disease identifies a novel replicated locus on chromosome 17. PLoS Genet. 2 (2006) e72
20. Fox C.S., Cupples L.A., Chazaro I., Polak J.F., Wolf P.A., D'Agostino R.B., Ordovas J.M., and O'Donnell C.J. Genomewide linkage analysis for internal carotid artery intimal medial thickness: evidence for linkage to chromosome 12. Am. J. Hum. Genet. 74 (2004) 253-261
21. Francke S., Manraj M., Lacquemant C., Lecoeur C., Lepretre F., Passa P., Hebe A., Corset L., Yan S.L., Lahmidi S., et al. A genome-wide scan for coronary heart disease suggests in Indo-Mauritians a susceptibility locus on chromosome 16p13 and replicates linkage with the metabolic syndrome on 3q27. Hum. Mol. Genet. 10 (2001) 2751-2765
22. Ghazalpour A., Wang X., Lusis A.J., and Mehrabian M. Complex inheritance of the 5-lipoxygenase locus influencing atherosclerosis in mice. Genetics 173 (2006) 943-951
23. Gonzalez P., Garcia-Castro M., Reguero J.R., Batalla A., Ordonez A.G., Palop R.L., Lozano I., Montes M., Alvarez V., and Coto E. The Pro279Leu variant in the transcription factor MEF2A is associated with myocardial infarction. J. Med. Genet. 43 (2006) 167-169
24. Gretarsdottir S., Sveinbjornsdottir S., Jonsson H.H., Jakobsson F., Einarsdottir E., Agnarsson U., Shkolny D., Einarsson G., Gudjonsdottir H.M., Valdimarsson E.M., et al. Localization of a susceptibility gene for common forms of stroke to 5q12. Am. J. Hum. Genet. 70 (2002) 593-603
25. Gudmundsson G., Matthiasson S.E., Arason H., Johannsson H., Runarsson F., Bjarnason H., Helgadottir K., Thorisdottir S., Ingadottir G., Lindpaintner K., et al. Localization of a gene for peripheral arterial occlusive disease to chromosome 1p31. Am. J. Hum. Genet. 70 (2002) 586-592
26. Hakonarson H., Thorvaldsson S., Helgadottir A., Gudbjartsson D., Zink F., Andresdottir M., Manolescu A., Arnar D.O., Andersen K., Sigurdsson A., et al. Effects of a 5-lipoxygenase-activating protein inhibitor on biomarkers associated with risk of myocardial infarction: a randomized trial. JAMA 293 (2005) 2245-2256
27. Hansson G.K., and Libby P. The immune response in atherosclerosis: a double-edged sword. Nat. Rev. Immunol. 6 (2006) 508-519
28. Harrap S.B., Zammit K.S., Wong Z.Y., Williams F.M., Bahlo M., Tonkin A.M., and Anderson S.T. Genome-wide linkage analysis of the acute coronary syndrome suggests a locus on chromosome 2. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 874-878
29. Hauser E.R., Crossman D.C., Granger C.B., Haines J.L., Jones C.J., Mooser V., McAdam B., Winkelmann B.R., Wiseman A.H., Muhlestein J.B., et al. A genomewide scan for early-onset coronary artery disease in 438 families: the GENECARD Study. Am. J. Hum. Genet. 75 (2004) 436-447
30. Helgadottir A., Manolescu A., Thorleifsson G., Gretarsdottir S., Jonsdottir H., Thorsteinsdottir U., Samani N.J., Gudmundsson G., Grant S.F., Thorgeirsson G., et al. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat. Genet. 36 (2004) 233-239
31. Helgadottir A., Gretarsdottir S., St Clair D., Manolescu A., Cheung J., Thorleifsson G., Pasdar A., Grant S.F., Whalley L.J., Hakonarson H., et al. Association between the gene encoding 5-lipoxygenase-activating protein and stroke replicated in a Scottish population. Am. J. Hum. Genet. 76 (2005) 505-509
32. Helgadottir A., Thorleifsson G., Manolescu A., Gretarsdottir S., Blondal T., Jonasdottir A., Jonasdottir A., Sigurdsson A., Baker A., Palsson A., et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 316 (2007) 1491-1493
33. Heller E.A., Liu E., Tager A.M., Sinha S., Roberts J.D., Koehn S.L., Libby P., Aikawa E.R., Chen J.Q., Huang P., et al. Inhibition of atherogenesis in BLT1-deficient mice reveals a role for LTB4 and BLT1 in smooth muscle cell recruitment. Circulation 112 (2005) 578-586
34. Hubner N., Wallace C.A., Zimdahl H., Petretto E., Schulz H., Maciver F., Mueller M., Hummel O., Monti J., Zidek V., et al. Integrated transcriptional profiling and linkage analysis for identification of genes underlying disease. Nat. Genet. 37 (2005) 243-253
35. Ishimori N., Li R., Kelmenson P.M., Korstanje R., Walsh K.A., Churchill G.A., Forsman-Semb K., and Paigen B. Quantitative trait loci analysis for plasma HDL-cholesterol concentrations and atherosclerosis susceptibility between inbred mouse strains C57BL/6J and 129S1/SvImJ. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 161-166
36. Jawien J., Gajda M., Rudling M., Mateuszuk L., Olszanecki R., Guzik T.J., Cichocki T., Chlopicki S., and Korbut R. Inhibition of five lipoxygenase activating protein (FLAP) by MK-886 decreases atherosclerosis in apoE/LDLR-double knockout mice. Eur. J. Clin. Invest. 36 (2006) 141-146
37. Kajimoto K., Shioji K., Ishida C., Iwanaga Y., Kokubo Y., Tomoike H., Miyazaki S., Nonogi H., Goto Y., and Iwai N. Validation of the association between the gene encoding 5-lipoxygenase-activating protein and myocardial infarction in a Japanese population. Circ. J. 69 (2005) 1029-1034
38. Kajimoto K., Shioji K., Tago N., Tomoike H., Nonogi H., Goto Y., and Iwai N. Assessment of MEF2A mutations in myocardial infarction in Japanese patients. Circ. J. 69 (2005) 1192-1195
39. Kaushal R., Pal P., Alwell K., Haverbusch M., Flaherty M., Moomaw C., Sekar P., Kissela B., Kleindorfer D., Chakraborty R., et al. Association of ALOX5AP with ischemic stroke: a population-based case-control study. Hum. Genet. 121 (2007) 601-607
40. Koch W., Hoppmann P., Mueller J.C., Schomig A., and Kastrati A. No association of polymorphisms in the gene encoding 5-lipoxygenase-activating protein and myocardial infarction in a large central European population. Genet. Med. 9 (2007) 123-129
41. Kopf M., Ruedl C., Schmitz N., Gallimore A., Lefrang K., Ecabert B., Odermatt B., and Bachmann M.F. OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL responses after virus infection. Immunity 11 (1999) 699-708
42. Korstanje R., Eriksson P., Samnegard A., Olsson P.G., Forsman-Semb K., Sen S., Churchill G.A., Rollins J., Harris S., Hamsten A., and Paigen B. Locating Ath8, a locus for murine atherosclerosis susceptibility and testing several of its candidate genes in mice and humans. Atherosclerosis 177 (2004) 443-450
43. Koster A., Chao Y.B., Mosior M., Ford A., Gonzalez-DeWhitt P.A., Hale J.E., Li D., Qiu Y., Fraser C.C., Yang D.D., et al. Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism. Endocrinology 146 (2005) 4943-4950
44. Kotani A., Hori T., Matsumura Y., and Uchiyama T. Signaling of gp34 (OX40 ligand) induces vascular endothelial cells to produce a CC chemokine RANTES/CCL5. Immunol. Lett. 84 (2002) 1-7
45. Lange L.A., Lange E.M., Bielak L.F., Langefeld C.D., Kardia S.L., Royston P., Turner S.T., Sheedy II P.F., Boerwinkle E., and Peyser P.A. Autosomal genome-wide scan for coronary artery calcification loci in sibships at high risk for hypertension. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 418-423
46. Laxton R., Pearce E., Kyriakou T., and Ye S. Association of the lymphotoxin-alpha gene Thr26Asn polymorphism with severity of coronary atherosclerosis. Genes Immun. 6 (2005) 539-541
47. Lohmussaar E., Gschwendtner A., Mueller J.C., Org T., Wichmann E., Hamann G., Meitinger T., and Dichgans M. ALOX5AP gene and the PDE4D gene in a central European population of stroke patients. Stroke 36 (2005) 731-736
48. Lusis A.J., Mar R., and Pajukanta P. Genetics of atherosclerosis. Annu. Rev. Genomics Hum. Genet. 5 (2004) 189-218
49. Mangino M., Braund P., Singh R., Steeds R., Thompson J.R., Channer K., and Samani N.J. LGALS2 functional variant rs7291467 is not associated with susceptibility to myocardial infarction in Caucasians. Atherosclerosis (2006) in press
50. McPherson R., Pertsemlidis A., Kavaslar N., Stewart A., Roberts R., Cox D.R., Hinds D.A., Pennacchio L.A., Tybjaerg-Hansen A., Folsom A.R., et al. A common allele on chromosome 9 associated with coronary heart disease. Science 316 (2007) 1488-1491
51. Mehrabian M., Wong J., Wang X., Jiang Z., Shi W., Fogelman A.M., and Lusis A.J. Genetic locus in mice that blocks development of atherosclerosis despite extreme hyperlipidemia. Circ. Res. 89 (2001) 125-130
52. Mehrabian M., Allayee H., Wong J., Shi W., Wang X.P., Shaposhnik Z., Funk C.D., Lusis A.J., and Shih W. Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice. Circ. Res. 91 (2002) 120-126
53. Meng H., Vera I., Che N., Wang X., Wang S.S., Ingram-Drake L., Schadt E.E., Drake T.A., and Lusis A.J. Identification of Abcc6 as the major causal gene for dystrophic cardiac calcification in mice through integrative genomics. Proc. Natl. Acad. Sci. USA 104 (2007) 4530-4535
54. Meschia J.F., Brott T.G., Brown Jr. R.D., Crook R., Worrall B.B., Kissela B., Brown W.M., Rich S.S., Case L.D., Evans E.W., et al. Phosphodiesterase 4D and 5-lipoxygenase activating protein in ischemic stroke. Ann. Neurol. 58 (2005) 351-361
55. Mizuno H., Sato H., Sakata Y., Ohnishi Y., Hishida E., Kinjo K., Nakatani D., Shimizu M., Kondo H., Tanaka T., et al. Impact of atherosclerosis-related gene polymorphisms on mortality and recurrent events after myocardial infarction. Atherosclerosis 185 (2006) 400-405
56. Monaco C., and Paleolog E. Nuclear factor kappaB: a potential therapeutic target in atherosclerosis and thrombosis. Cardiovasc. Res. 61 (2004) 671-682
57. Mu J.L., Naggert J.K., Svenson K.L., Collin G.B., Kim J.H., McFarland C., Nishina P.M., Levine D.M., Williams K.J., and Paigen B. Quantitative trait loci analysis for the differences in susceptibility to atherosclerosis and diabetes between inbred mouse strains C57BL/6J and C57BLKS/J. J. Lipid Res. 40 (1999) 1328-1335
58. Murata K., Ishii N., Takano H., Miura S., Ndhlovu L.C., Nose M., Noda T., and Sugamura K. Impairment of antigen-presenting cell function in mice lacking expression of OX40 ligand. J. Exp. Med. 191 (2000) 365-374
59. Nilsson-Ardnor S., Wiklund P.G., Lindgren P., Nilsson A.K., Janunger T., Escher S.A., Hallbeck B., Stegmayr B., Asplund K., and Holmberg D. Linkage of ischemic stroke to the PDE4D region on 5q in a Swedish population. Stroke 36 (2005) 1666-1671
60. Ozaki K., Ohnishi Y., Iida A., Sekine A., Yamada R., Tsunoda T., Sato H., Sato H., Hori M., Nakamura Y., and Tanaka T. Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat. Genet. 32 (2002) 650-654
61. Ozaki K., Inoue K., Sato H., Iida A., Ohnishi Y., Sekine A., Sato H., Odashiro K., Nobuyoshi M., Hori M., et al. Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin-alpha secretion in vitro. Nature 429 (2004) 72-75
62. Paigen B. Genetics of responsiveness to high-fat and high-cholesterol diets in the mouse. Am. J. Clin. Nutr. 62 (1995) 458S-462S
63. Paigen B., Albee D., Holmes P.A., and Mitchell D. Genetic analysis of murine strains C57BL/6J and C3H/HeJ to confirm the map position of Ath-1, a gene determining atherosclerosis susceptibility. Biochem. Genet. 25 (1987) 501-511
64. Paigen B., Mitchell D., Holmes P.A., and Albee D. Genetic analysis of strains C57BL/6J and BALB/cJ for Ath-1, a gene determining atherosclerosis susceptibility in mice. Biochem. Genet. 25 (1987) 881-892
65. Paigen B., Mitchell D., Reue K., Morrow A., Lusis A.J., and LeBoeuf R.C. Ath-1, a gene determining atherosclerosis susceptibility and high density lipoprotein levels in mice. Proc. Natl. Acad. Sci. USA 84 (1987) 3763-3767
66. Pajukanta P., Cargill M., Viitanen L., Nuotio I., Kareinen A., Perola M., Terwilliger J.D., Kempas E., Daly M., Lilja H., et al. Two loci on chromosomes 2 and X for premature coronary heart disease identified in early- and late-settlement populations of Finland. Am. J. Hum. Genet. 67 (2000) 1481-1493
67. Phelan S.A., Beier D.R., Higgins D.C., and Paigen B. Confirmation and high resolution mapping of an atherosclerosis susceptibility gene in mice on Chromosome 1. Mamm. Genome 13 (2002) 548-553
68. Pletcher M.T., McClurg P., Batalov S., Su A.I., Barnes S.W., Lagler E., Korstanje R., Wang X., Nusskern D., Bogue M.A., et al. Use of a dense single nucleotide polymorphism map for in silico mapping in the mouse. PLoS Biol. 2 (2004) e393
69. PROCARDIS Consortium. A trio family study showing association of the lymphotoxin-alpha N26 (804A) allele with coronary artery disease. Eur. J. Hum. Genet. 12 (2004) 770-774
70. Qiu H., Gabrielsen A., Agardh H.E., Wan M., Wetterholm A., Wong C.H., Hedin U., Swedenborg J., Hansson G.K., Samuelsson B., et al. Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability. Proc. Natl. Acad. Sci. USA 103 (2006) 8161-8166
71. Ria M., Eriksson P., Boquist S., Ericsson C.G., Hamsten A., and Lagercrantz J. Human genetic evidence that OX40 is implicated in myocardial infarction. Biochem. Biophys. Res. Commun. 339 (2006) 1001-1006
72. Rollins J., Chen Y., Paigen B., and Wang X. In search of new targets for plasma high-density lipoprotein cholesterol levels: promise of human-mouse comparative genomics. Trends Cardiovasc. Med. 16 (2006) 220-234
73. Samani N.J., Burton P., Mangino M., Ball S.G., Balmforth A.J., Barrett J., Bishop T., and Hall A. A genomewide linkage study of 1,933 families affected by premature coronary artery disease: The British Heart Foundation (BHF) Family Heart Study. Am. J. Hum. Genet. 77 (2005) 1011-1020
74. Seidelmann S.B., De Luca C., Leibel R.L., Breslow J.L., Tall A.R., and Welch C.L. Quantitative trait locus mapping of genetic modifiers of metabolic syndrome and atherosclerosis in low-density lipoprotein receptor-deficient mice: identification of a locus for metabolic syndrome and increased atherosclerosis on chromosome 4. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 204-210
75. Shiffman D., Ellis S.G., Rowland C.M., Malloy M.J., Luke M.M., Iakoubova O.A., Pullinger C.R., Cassano J., Aouizerat B.E., Fenwick R.G., et al. Identification of four gene variants associated with myocardial infarction. Am. J. Hum. Genet. 77 (2005) 596-605
76. Shiffman D., Rowland C.M., Louie J.Z., Luke M.M., Bare L.A., Bolonick J.I., Young B.A., Catanese J.J., Stiggins C.F., Pullinger C.R., et al. Gene variants of VAMP8 and HNRPUL1 are associated with early-onset myocardial infarction. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 1613-1618
77. Smith J.D., Bhasin J.M., Baglione J., Settle M., Xu Y., and Barnard J. Atherosclerosis susceptibility loci identified from a strain intercross of apolipoprotein E-deficient mice via a high-density genome scan. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 597-603
78. Stewart-Phillips J.L., Lough J., and Skamene E. ATH-3, a new gene for atherosclerosis in the mouse. Clin. Invest. Med. 12 (1989) 121-126
79. Su Z., Li Y., James J.C., McDuffie M., Matsumoto A.H., Helm G.A., Weber J.L., Lusis A.J., and Shi W. Quantitative trait locus analysis of atherosclerosis in an intercross between C57BL/6 and C3H mice carrying the mutant apolipoprotein E gene. Genetics 172 (2006) 1799-1807
80. Subbarao K., Jala V.R., Mathis S., Suttles J., Zacharias W., Ahamed J., Ali H., Tseng M.T., and Haribabu B. Role of leukotriene B4 receptors in the development of atherosclerosis: potential mechanisms. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 369-375
81. Sugamura K., Ishii N., and Weinberg A.D. Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40. Nat. Rev. Immunol. 4 (2004) 420-431
82. Teupser D., Tan M., Persky A.D., and Breslow J.L. Atherosclerosis quantitative trait loci are sex- and lineage-dependent in an intercross of C57BL/6 and FVB/N low-density lipoprotein receptor-/- mice. Proc. Natl. Acad. Sci. USA 103 (2006) 123-128
83. Todd J., and Farmer J.A. Optimal low-density lipoprotein levels: evidence from epidemiology and clinical trials. Curr. Atheroscler. Rep. 8 (2006) 157-162
84. Turner S.T., Peyser P.A., Kardia S.L., Bielak L.F., Sheedy III P.F., Boerwinkle E., and de Andrade M. Genomic loci with pleiotropic effects on coronary artery calcification. Atherosclerosis 185 (2005) 340-346
85. van Wanrooij E.J., van Puijvelde G.H., de Vos P., Yagita H., van Berkel T.J., and Kuiper J. Interruption of the Tnfrsf4/Tnfsf4 (OX40/OX40L) pathway attenuates atherogenesis in low-density lipoprotein receptor-deficient mice. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 204-210
86. Veillard N.R., Kwak B., Pelli G., Mulhaupt F., James R.W., Proudfoot A.E., and Mach F. Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice. Circ. Res. 94 (2004) 253-261
87. Wang D., Yang H., Quinones M.J., Bulnes-Enriquez I., Jimenez X., De La Rosa R., Modilevsky T., Yu K., Li Y., Taylor K.D., et al. A genome-wide scan for carotid artery intima-media thickness: the Mexican-American Coronary Artery Disease family study. Stroke 36 (2005) 540-545
88. Wang L., Fan C., Topol S.E., Topol E.J., and Wang Q. Mutation of MEF2A in an inherited disorder with features of coronary artery disease. Science 302 (2003) 1578-1581
89. Wang L., Hauser E.R., Shah S.H., Pericak-Vance M.A., Haynes C., Crosslin D., Harris M., Nelson S., Hale A.B., Granger C.B., et al. Peakwide mapping on chromosome 3q13 identifies the kalirin gene as a novel candidate gene for coronary artery disease. Am. J. Hum. Genet. 80 (2007) 650-663
90. Wang Q., Rao S., Shen G.Q., Li L., Moliterno D.J., Newby L.K., Rogers W.J., Cannata R., Zirzow E., Elston R.C., and Topol E.J. Premature myocardial infarction novel susceptibility locus on chromosome 1p34-36 identified by genomewide linkage analysis. Am. J. Hum. Genet. 74 (2004) 262-271
91. Wang S., Shi W., Wang X., and Lusis A.J. Identification of a locus in mice that influences aortic aneurysm formation. Circ. Res. 108 (2003) IV-177
92. Wang X. T-cell co-stimulators as anti-inflammatory targets for atherosclerotic disease. Future Cardiol. 2 (2006) 187-195
93. Wang X., and Paigen B. Genetics of variation in HDL cholesterol in humans and mice. Circ. Res. 96 (2005) 27-42
94. Wang X., and Paigen B. Genome-wide search for new genes controlling plasma lipid concentrations in mice and humans. Curr. Opin. Lipidol. 16 (2005) 127-137
95. Wang X., Ishimori N., Korstanje R., Rollins J., and Paigen B. Identifying novel genes for atherosclerosis through mouse-human comparative genetics. Am. J. Hum. Genet. 77 (2005) 1-15
96. Wang X., Ria M., Kelmenson P.M., Eriksson P., Higgins D.C., Samnegard A., Petros C., Rollins J., Bennet A.M., Wiman B., et al. Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility. Nat. Genet. 37 (2005) 365-372
97. Welch C.L., Bretschger S., Latib N., Bezouevski M., Guo Y., Pleskac N., Liang C.P., Barlow C., Dansky H., Breslow J.L., and Tall A.R. Localization of atherosclerosis susceptibility loci to chromosomes 4 and 6 using the Ldlr knockout mouse model. Proc. Natl. Acad. Sci. USA 98 (2001) 7946-7951
98. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447 (2007) 661-678
99. Weng L., Kavaslar N., Ustaszewska A., Doelle H., Schackwitz W., Hebert S., Cohen J.C., McPherson R., and Pennacchio L.A. Lack of MEF2A mutations in coronary artery disease. J. Clin. Invest. 115 (2005) 1016-1020
100. Yaguchi H., Togawa K., Moritani M., and Itakura M. Identification of candidate genes in the type 2 diabetes modifier locus using expression QTL. Genomics 85 (2005) 591-599
101. Zee R.Y., Cheng S., Hegener H.H., Erlich H.A., and Ridker P.M. Genetic variants of arachidonate 5-lipoxygenase-activating protein, and risk of incident myocardial infarction and ischemic stroke: a nested case-control approach. Stroke 37 (2006) 2007-2011
102. Zhao L., Moos M.P., Grabner R., Pedrono F., Fan J., Kaiser B., John N., Schmidt S., Spanbroek R., Lotzer K., et al. The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm. Nat. Med. 10 (2004) 966-973
103. Zintzaras E., and Kitsios G. Identification of chromosomal regions linked to premature myocardial infarction: a meta-analysis of whole-genome searches. J. Hum. Genet. 51 (2006) 1015-1021